Chemotherapy in hormone-refractory prostate cancer

被引：1
作者：
Biedermann, B [1 ]
Pless, M [1 ]
Herrmann, R [1 ]
机构：
[1] Kantonsspital, Dept Innere Med, Abt Onkol, CH-4031 Basel, Switzerland
来源：
DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT | 1999年 / 124卷 / 28-29期
关键词：
D O I：
10.1055/s-2007-1024434
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：874 / 879
页数：6
相关论文
共 57 条
[1]   PANETH CELL-LIKE CHANGE IN PROSTATIC ADENOCARCINOMA REPRESENTS NEUROENDOCRINE DIFFERENTIATION - REPORT OF 30 CASES [J].
ADLAKHA, H ;
BOSTWICK, DG .
HUMAN PATHOLOGY, 1994, 25 (02) :135-139
[2]   CHEMOTHERAPY FOR SMALL-CELL CARCINOMA OF PROSTATIC ORIGIN [J].
AMATO, RJ ;
LOGOTHETIS, CJ ;
HALLINAN, R ;
RO, JY ;
SELLA, A ;
DEXEUS, FH .
JOURNAL OF UROLOGY, 1992, 147 (03) :935-937
[3]  
CATALONA WJ, 1994, NEW ENGL J MED, V331, P996
[4]  
CRUCIANI G, 1998, P AN M AM SOC CLIN, V17, pA329
[5]   Apples and oranges: Building a consensus for standardized eligibility criteria and end points in prostate cancer clinical trials [J].
Dawson, NA .
JOURNAL OF CLINICAL ONCOLOGY, 1998, 16 (10) :3398-3405
[6]  
DISANTAGNESE PA, 1992, HUM PATHOL, V23, P287
[7]   RESPONSE TO FLUTAMIDE WITHDRAWAL IN ADVANCED PROSTATE-CANCER IN PROGRESSION UNDER COMBINATION THERAPY [J].
DUPONT, A ;
GOMEZ, JL ;
CUSAN, L ;
KOUTSILIERIS, M ;
LABRIE, F .
JOURNAL OF UROLOGY, 1993, 150 (03) :908-913
[8]  
Eisenberger M A, 1988, Semin Urol, V6, P303
[9]  
EISENBERGER MA, 1994, SEMIN ONCOL, V21, P613
[10]  
Ellerhorst JA, 1997, CLIN CANCER RES, V3, P2371
123456